# Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo

> **NCT04096170** · PHASE4 · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 50 (estimated)

## Conditions studied

- Hernia, Paraesophageal

## Interventions

- **DRUG:** IV lidocaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04096170
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-21
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096170, "Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04096170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*